210 related articles for article (PubMed ID: 1173962)
21. Insulin antibody formation. I. The influence of age, sex, infections, insulin dosage and regulation of diabetes.
Andersen OO
Acta Endocrinol (Copenh); 1972 Sep; 71(1):126-40. PubMed ID: 4678008
[No Abstract] [Full Text] [Related]
22. [Insulin-binding antibodies and insulin resistance (author's transl)].
Waldhäusl W
Wien Klin Wochenschr; 1973 Dec; 85(51):833-6. PubMed ID: 4272340
[No Abstract] [Full Text] [Related]
23. Clinical significance of anti-insulin-antibodies.
Andersen OO
Acta Endocrinol Suppl (Copenh); 1976; 205():231-40. PubMed ID: 1087092
[TBL] [Abstract][Full Text] [Related]
24. [KH metabolic pattern and insulin antibody level during treatment of diabetes mellitus with conventional and/or prepurified insulin preparations].
Göbel P; Kramer W; Heni F
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1426-9. PubMed ID: 611859
[No Abstract] [Full Text] [Related]
25. [Clinical use of NPH insulin (author's transl)].
Roesner M; Sauer H
Dtsch Med Wochenschr; 1976 Jun; 101(23):886-9. PubMed ID: 1269430
[TBL] [Abstract][Full Text] [Related]
26. Is there a relationship between genetically determined haptoglobin phenotype and insulin-dependent diabetes mellitus (IDDM)?
Ratzmann KP; Strese J; Keilacker H; Giebelmann R; Scheibe F; Witt S
Exp Clin Endocrinol; 1984 Apr; 83(2):207-15. PubMed ID: 6539222
[TBL] [Abstract][Full Text] [Related]
27. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
28. [The study of insulin antibodies in different forms of diabetes mellitus].
Mincu I; Ionescu-Tirgovişte C; Cheţa D; Simionescu L; Mirodon Z; Vasilescu V; Bruckner I
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):421-8. PubMed ID: 44565
[No Abstract] [Full Text] [Related]
29. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
Andreani D; Iavicoli M; Colletti A; Menzinger G
Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
[No Abstract] [Full Text] [Related]
30. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
[TBL] [Abstract][Full Text] [Related]
31. C-peptide antibodies induced by bovine insulin therapy.
Reeves WG; Douglas CA
Clin Exp Immunol; 1982 Oct; 50(1):171-7. PubMed ID: 6756729
[TBL] [Abstract][Full Text] [Related]
32. [Preliminary note on anti-insulin antibody formation in diabetics treated with porcine insulin].
Bchir F; Boujaafar N; Ben Salem M; Achour A
Arch Inst Pasteur Tunis; 1984 Mar; 61(1):1-8. PubMed ID: 6398991
[TBL] [Abstract][Full Text] [Related]
33. Insulin binding and free insulin in serum of insulin-treated diabetics.
Lev-Ran A; Ratt L
Horm Metab Res; 1973 Mar; 5(2):67-70. PubMed ID: 4707702
[No Abstract] [Full Text] [Related]
34. Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin.
Piers DA; Sluiter WJ; Reitsma WD; Doorenbos H
Neth J Med; 1974; 17(4-5):234-8. PubMed ID: 4465730
[No Abstract] [Full Text] [Related]
35. Circulating antibodies in diabetics treated with conventional and purified insulins.
Klaff LJ; Vinik AI; Berelowitz M; Jackson WP
S Afr Med J; 1978 Jul; 54(4):149-53. PubMed ID: 694712
[TBL] [Abstract][Full Text] [Related]
36. The immunogenic properties of a highly purified insulin preparation.
Manning NT; Drury MI
Ir J Med Sci; 1979 Apr; 148(4):135-9. PubMed ID: 393651
[No Abstract] [Full Text] [Related]
37. Long-term clinical trial with porcine monocomponent lente insulin (Monotard).
Bruni B; Bruni Bocher K; Gamba S; Giolitti A; Rittatore R; Turco GL
Panminerva Med; 1977; 19(4):247-54. PubMed ID: 593701
[No Abstract] [Full Text] [Related]
38. Total insulin levels in type 1 diabetic patients with insulin antibodies and their effect on insulin requirement and metabolic control.
Hübinger A; Becker A; Gries FA
Diabetes Res; 1988 Feb; 7(2):65-9. PubMed ID: 3293878
[TBL] [Abstract][Full Text] [Related]
39. Insulin autoantibodies: more specific than proinsulin autoantibodies for prediction of type 1 diabetes.
Williams AJ; Bingley PJ; Chance RE; Gale EA
J Autoimmun; 1999 Nov; 13(3):357-63. PubMed ID: 10550223
[TBL] [Abstract][Full Text] [Related]
40. [Long-term clinical results with monocomponent insulin (MC lente) in infantile and juvenile diabetes].
Bruni KB; Neirotti R; Albonico G; Gamba S; Regis G; D'Adda A; Soldano E; Bruni B
Ann Osp Maria Vittoria Torino; 1976; 19(16):7-26. PubMed ID: 1027349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
